SCHEMBL6795178

SCHEMBL6795178

Cc1ccnc2c1C(=O)CC(c1cc(F)ccc1F)C2

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6804541 0.91 ALPL (0.41) ALPL
SCHEMBL7683160 0.90 ALPL (0.41) ALPL
SCHEMBL7687647 0.90
SCHEMBL7689308 0.88 ALPL (0.39) ALPL
SCHEMBL6802858 0.88
Hydrochloric Acid SCHEMBL7687669 0.88
Hydrochloric Acid SCHEMBL7686926 0.85 LMNA (0.41)
SCHEMBL7680811 0.85
SCHEMBL7683315 0.82 ALPL (0.60) ALPL
SCHEMBL7683538 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6706732-B1 PROPHYLACTIC AND THERAPEUTIC EFFECT ON MYOCARDIAL INFARCTION AND ACCOMPANYING DYSFUNCTIONS, ARRHYTHMIA, UNSTABLE ANGINA, CARDIAC HYPERTROPHY, ETC.; SODIUM-PROTON EXCHANGE INHIBITION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-16 US disclosed
EP-1182194-A1 PERNASAL PREPARATIONS Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed